The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The makers of Aranesp, Epogen and Procrit have recently been advised by the FDA to expand its black box warnings. The new warnings indicate the risks of death and tumor growth when used by cancer patients with early stage breast cancer or cancer in the head and neck. Aransep, Epogen and Procrit are popular drugs used to treat the blood disorder anemia in patients with kidney failure and those on chemotherapy. If you, or a family member has been injured by this drug, contact Sheller PC to get more information about your legal rights. We have a team of experienced attorneys who are willing to assist you in every aspect of your case.

Comments are closed.

Of Interest